Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Identification of carboxyl-terminal peptide fragments of parathyroid hormone in human plasma at low-picomolar levels by mass spectrometry.

Zhang CX, Weber BV, Thammavong J, Grover TA, Wells DS.

Anal Chem. 2006 Mar 1;78(5):1636-43.

PMID:
16503617
2.

Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.

Flueck JA, Di Bella FP, Edis AJ, Kehrwald JM, Arnaud CD.

J Clin Invest. 1977 Dec;60(6):1367-75.

3.
4.

Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications.

Brossard JH, Yamamoto LN, D'Amour P.

Semin Dial. 2002 May-Jun;15(3):196-201. Review.

PMID:
12100458
5.

Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.

D'Amour P, Brossard JH, Räkel A, Rousseau L, Albert C, Cantor T.

Clin Chem. 2005 Jan;51(1):169-76. Epub 2004 Oct 28.

6.

Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone.

Gao P, Schmidt-Gayk H, Dittrich K, Nolting B, Maier A, Roth HJ, Seemann O, Reichel H, Ritz E, Schilling T.

Clin Chim Acta. 1996 Feb 9;245(1):39-59.

PMID:
8646814
7.

Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.

Hofmann S, Glückmann M, Kausche S, Schmidt A, Corvey C, Lichtenfels R, Huber C, Albrecht C, Karas M, Herr W.

Mol Cell Proteomics. 2005 Dec;4(12):1888-97. Epub 2005 Aug 19.

8.

Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants.

Lopez MF, Rezai T, Sarracino DA, Prakash A, Krastins B, Athanas M, Singh RJ, Barnidge DR, Oran P, Borges C, Nelson RW.

Clin Chem. 2010 Feb;56(2):281-90. doi: 10.1373/clinchem.2009.137323. Epub 2009 Dec 18.

10.

Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.

Chunxiao W, Jingjing L, Yire X, Min D, Zhaohui W, Gaofu Q, Xiangchun S, Xuejun W, Jie W, Taiming L.

Regul Pept. 2007 Jun 7;141(1-3):35-43. Epub 2007 Jan 11.

PMID:
17300845
12.

Isolation and characterization of the bioactive circulating human parathyroid hormone, hPTH-1-37.

Hock D, Mägerlein M, Heine G, Ochlich PP, Forssmann WG.

FEBS Lett. 1997 Jan 3;400(2):221-5.

13.

Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution.

Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, Smiley DL, Tashjian AH, Zhang F.

J Biol Chem. 2000 Sep 1;275(35):27238-44.

14.

Immunoassays for the detection of parathyroid hormone.

Jüppner H, Potts JT Jr.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N81-6. Review.

PMID:
12412782
15.
16.

Metabolic stability of human parathyroid hormone peptide hPTH (1-34) in rat tissue homogenates: kinetics and products of proteolytic degradation.

Liao S, Qie JK, Xue M, Zhang ZQ, Liu KL, Ruan JX.

Amino Acids. 2010 May;38(5):1595-605. doi: 10.1007/s00726-009-0376-y. Epub 2009 Nov 6.

PMID:
19894098
17.
18.

Calcium-activated proteases in the bovine parathyroid gland: potential role in degradation of parathyroid hormone to peptide fragments.

Waton PH, Mortimer ST, Wang KK, Croall DE, Hanley DA.

J Mol Endocrinol. 1995 Aug;15(1):61-71.

PMID:
8546814
19.

Selective determination of C-terminal (70-84) hPTH: elevated concentrations in cholestatic liver disease.

Rittinghaus EF, Jüppner H, Burdelski M, Hesch RD.

Acta Endocrinol (Copenh). 1986 Jan;111(1):62-8.

PMID:
3946104
20.

Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.

Herberth J, Fahrleitner-Pammer A, Obermayer-Pietsch B, Krisper P, Holzer H, Malluche HH, Dobnig H.

Clin Nephrol. 2006 May;65(5):328-34.

PMID:
16724653

Supplemental Content

Support Center